Abstract
According to the "two-step model," the intrathymic generation of CD4(+) regulatory T (T-reg) cells segregates into a first, T cell receptor (TCR)-driven phase and a second, cytokine-dependent phase. The initial TCR stimulus gives rise to a CD25(+)Foxp3(-) developmental intermediate. These precursors subsequently require cytokine signaling to establish the mature CD25(+)Foxp3(+) T-reg cell phenotype. In addition, costimulation via CD28/B7 (CD80/86) axis is important for the generation of a T-reg cell repertoire of normal size. Recent data suggest that CD28 or B7 deficient mice lack CD25(+)Foxp3(-) T-reg cell progenitors. However, these data leave open whether costimulation is also required at subsequent stages of T-reg differentiation. Also, the fate of ``presumptive'' T-reg cells carrying a permissive TCR specificity in the absence of costimulation remains to be established. Here, we have used a previously described TCR transgenic model of agonist-driven T-reg differentiation in order to address these issues. Intrathymic adoptive transfer of T-reg precursors indicated that costimulation is dispensable once the intermediate CD25(+)Foxp3(-) stage has been reached. Furthermore, lack of costimulation led to the physical loss of presumptive T-reg cells rather than their escape from central tolerance and differentiation into the conventional CD4(+) T cell lineage. Our findings suggest that CD28 signaling does not primarily operate through enhancing the TCR signal strength in order to pass the threshold intensity required to initiate T-reg cell specification. Instead, costimulation seems to deliver unique and qualitatively distinct signals that coordinately foster the developmental progression of T-reg precursors and prevent their negative selection.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Keywords: | regulatory T cell; thymocyte development; thymus; tolerance; costimulation; thymus epithelium; CD28; B7 |
Fakultät: | Medizin > Institut für Immunologie |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
URN: | urn:nbn:de:bvb:19-epub-36860-1 |
ISSN: | 1664-3224 |
Ort: | PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND |
Sprache: | Englisch |
Dokumenten ID: | 36860 |
Datum der Veröffentlichung auf Open Access LMU: | 05. Apr. 2017, 15:09 |
Letzte Änderungen: | 04. Nov. 2020, 13:14 |